References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Nimatoudis et al., 2004",46,venlafaxine: 75-150 mg/day,NA,66.7,27.1,41,20.8,Wyeth Hellas,8,dsm-iv
"Nimatoudis et al., 2004",46,placebo,NA,68.2,28.5,44,50.0,Wyeth Hellas,8,dsm-iv
